Rima McLeod to Toxoplasmosis, Ocular
This is a "connection" page, showing publications Rima McLeod has written about Toxoplasmosis, Ocular.
Connection Strength
1.672
-
Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis. Infect Immun. 2018 04; 86(4).
Score: 0.648
-
Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. Pediatr Infect Dis J. 2006 Mar; 25(3):270-2.
Score: 0.281
-
Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol. 2000 Jan; 22(1):1-5.
Score: 0.183
-
Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011 Apr; 19(2):91-102.
Score: 0.100
-
Host genetic and epigenetic factors in toxoplasmosis. Mem Inst Oswaldo Cruz. 2009 Mar; 104(2):162-9.
Score: 0.086
-
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol. 2008 Aug; 126(8):1152-6.
Score: 0.083
-
Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol. 2008 Sep; 146(3):375-384.
Score: 0.083
-
Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology. 2008 Mar; 115(3):553-559.e8.
Score: 0.078
-
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics. 2006 Aug; 118(2):e379-90.
Score: 0.072
-
Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol. 2003 Jun; 135(6):779-84.
Score: 0.058